Cancer cells that activate the ALT pathway can continue to divide indefinitely, which is a hallmark of cancer known as immortality. Since telomerase is inactive in these cells, targeting the ALT pathway presents a potential therapeutic strategy. Understanding the mechanisms of ALT could lead to novel cancer therapies that specifically target cancer cells while sparing normal cells, which usually do not rely on the ALT pathway.
